A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations - Join Clinical Trial NCTNCT06706076
How to Join This Clinical Trial - NCTNCT06706076
Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for NSCLC (Advanced Non-small Cell Lung Cancer). This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with NSCLC (Advanced Non-small Cell Lung Cancer). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- NSCLC (Advanced Non-small Cell Lung Cancer)
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1, PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06706076 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 10 locations. Find a study site near you:
Clinical Research Site
Irvine, California 92697 - United States
Status: RECRUITING
Clinical Research Site
La Jolla, California 92093 - United States
Status: RECRUITING
Clinical Research Site
Sacramento, California 95817 - United States
Status: RECRUITING
Clinical Research Site
Lake Mary, Florida 32746 - United States
Status: RECRUITING
Clinical Research Site
Chicago, Illinois 60611 - United States
Status: RECRUITING
Clinical Research Site
Nashville, Tennessee 37203 - United States
Status: RECRUITING
Clinical Research Site
Houston, Texas 77030 - United States
Status: RECRUITING
Clinical Research Site
Fairfax, Virginia 22031 - United States
Status: RECRUITING
Clinical Research Site
Kashiwa, Chiba 227-8577 - Japan
Status: RECRUITING
Clinical Research Site
Tsukiji, Tokyo - Japan
Status: RECRUITING
How to Enroll in This Study
To learn more about participating in this PHASE1, PHASE2 clinical trial for NSCLC (Advanced Non-small Cell Lung Cancer):
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships